Follow
Guillermo García Marquina
Guillermo García Marquina
Development Scientist, New England Biolabs
Verified email at neb.com
Title
Cited by
Cited by
Year
Fidelity of classwide-resistant HIV-2 reverse transcriptase and differential contribution of K65R to the accuracy of HIV-1 and HIV-2 reverse transcriptases
M Álvarez, A Sebastián-Martín, G García-Marquina, L Menéndez-Arias
Scientific Reports 7 (1), 44834, 2017
172017
Immobilization and stabilization of an engineered acyltransferase for the continuous biosynthesis of simvastatin in packed-bed reactors
G García-Marquina, J Langer, M Sánchez-Costa, G Jiménez-Osés, ...
ACS Sustainable Chemistry & Engineering 10 (30), 9899-9910, 2022
102022
Deconvoluting the directed evolution pathway of engineered acyltransferase LovD
G García‐Marquina, R Núñez‐Franco, F Peccati, Y Tang, ...
ChemCatChem 14 (4), e202101349, 2022
62022
ATP‐Independent and Cell‐Free Biosynthesis of β‐Hydroxy Acids Using Vinyl Esters as Smart Substrates
AH Orrego, MG Rubanu, IL López, D Andrés‐Sanz, G García‐Marquina, ...
Angewandte Chemie International Edition 62 (13), e202218312, 2023
32023
Expanding the substrate scope of acyltransferase LovD9 for the biosynthesis of statin analogues
G García‐Marquina, R Núñez‐Franco, D Grajales‐Hernández, ...
Chemistry–A European Journal 29 (42), e202300911, 2023
12023
Immobilized enzyme compositions and methods
MS Ming-Qun Xu, Guillermo García-Marquina, Siu-Hong Chan, Ivan R. Correa, JR ...
US Patent US20230287376A1, 2023
2023
Acyltransferase LovD as a Simvastatin Synthase: Mutational Deconvolution, Design, Substrate Scope and Immobilization
GG Marquina
Universidad de La Rioja, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–7